Device Reclassification Petition
Formal request to FDA to move a device type from one classification (I, II, or III) to another, either down-classifying or up-classifying.
Definition
A reclassification petition is a formal submission asking FDA to change the regulatory classification of a generic type of device. Section 513(e) of the FD&C Act authorizes FDA-initiated reclassification; Section 513(f)(3) authorizes manufacturer-initiated petitions. Petitions must include valid scientific evidence showing that the device type warrants a different classification, typically that risks can be adequately controlled by general or special controls (down-classification from III to II) or that existing controls are insufficient (up-classification).What this means in practice
Reclassification is uncommon but strategically powerful. Down-classifying a Class III device type to Class II eliminates the PMA burden for the entire device class, affecting every competitor. FDA periodically reclassifies device types based on accumulated post-market evidence (e.g., reclassification of certain external defibrillators, some surgical staplers). Manufacturer-initiated petitions typically come from industry consortia rather than individual companies because the benefits accrue to all competitors.- •Treating a reclassification petition as a substitute for a 510(k) or De Novo, petitions reclassify the entire generic type, not individual products.
- •Underestimating the evidence bar, FDA requires comprehensive scientific evidence about the device type's risk profile across the market.
- •Ignoring the public comment and Federal Register process, reclassifications go through formal rulemaking.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsFDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
FDA's highest-risk device class, generally requiring PMA.
Pathway to classify novel low- to moderate-risk devices that lack a predicate.
Baseline FDA requirements that apply to all medical devices regardless of class.
More in Regulatory
· Same categoryFDA's most stringent device marketing application, required for high-risk Class III devices.
Device-type-specific FDA requirements (often performance standards, labeling, or post-market surveillance) that apply on top of General Controls.
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
Primary references
3 sources- 1
Reclassification of Medical Devices GuidanceVerifiedFDAfda.gov
- 2
21 CFR Part 860 Subpart CVerifiedeCFRecfr.gov
- 3
IMDRF DocumentsVerifiedIMDRFimdrf.org
Inline markers like [1] jump to the matching reference above.